Valuation: AstraZeneca PLC

Market Cap 241B 366,686B 215B 200B 182B 344B 23,231B 346B 2,420B 941B 11,847B 906B 886B 38,096B P/E 2026 *
19.8x
P/E 2027 * 17.3x
Enterprise Value 261B 396,861B 233B 217B 197B 372B 25,143B 374B 2,619B 1,018B 12,822B 980B 959B 41,231B EV / Sales 2026 *
4.13x
EV / Sales 2027 * 3.78x
Free-Float
96.62%
Yield 2026 *
2.15%
Yield 2027 * 2.28%
1 day-1.10%
1 week-6.57%
Current month-3.71%
1 month-2.44%
3 months-21.28%
6 months-15.58%
Current year-10.74%
1 week 62,475
Extreme 62475
67,200
1 month 61,000
Extreme 61000
68,000
Current year 60,650
Extreme 60650
80,275
1 year 54,750
Extreme 54750
80,275
3 years 24,288
Extreme 24288
80,275
5 years 5,438.5
Extreme 5438.5
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 30/09/2012
Director of Finance/CFO 52 31/07/2021
Compliance Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member 70 05/04/1999
Director/Board Member 66 30/09/2012
Director/Board Member 65 26/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-6.57% - - 244B
+0.02%-3.41%+36.11%+115.09% 1,019B
-1.21%-6.74%+34.08%+62.64% 617B
+1.12%+0.54%+13.62%+79.94% 464B
-3.30%-6.21%+56.45%+36.58% 356B
+0.93%-3.16%+21.65%+43.02% 333B
+0.12%-2.77%+10.70%+32.97% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-2.81%+35.28%+51.82% 218B
-0.08%-4.17%+28.34%+93.51% 179B
Average -0.37%-3.54%+25.47%+58.17% 410.8B
Weighted average by Cap. -0.11%-3.54%+28.50%+70.11%

Financials

2026 *2027 *
Net sales 63.17B 96,015B 56.29B 52.47B 47.77B 90.04B 6,083B 90.59B 634B 246B 3,102B 237B 232B 9,975B 67.04B 101,901B 59.75B 55.69B 50.7B 95.56B 6,456B 96.15B 673B 261B 3,292B 252B 246B 10,587B
Net income 12.04B 18,296B 10.73B 10B 9.1B 17.16B 1,159B 17.26B 121B 46.94B 591B 45.19B 44.21B 1,901B 13.78B 20,939B 12.28B 11.44B 10.42B 19.64B 1,327B 19.76B 138B 53.72B 677B 51.72B 50.59B 2,175B
Net Debt 19.85B 30,175B 17.69B 16.49B 15.01B 28.3B 1,912B 28.47B 199B 77.42B 975B 74.53B 72.91B 3,135B 12.08B 18,364B 10.77B 10.04B 9.14B 17.22B 1,163B 17.33B 121B 47.12B 593B 45.36B 44.37B 1,908B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
05/10/26 ARS 62,975.00 -1.10% 130
02/10/26 ARS 63,675.00 -0.74% 621
01/10/26 ARS 64,150.00 -1.91% 85
30/09/26 ARS 65,400.00 -1.32% 113
29/09/26 ARS 66,275.00 -1.45% 161
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
155.54USD
Average target price
209.82USD
Spread / Average Target
+34.90%

Quarterly revenue - Rate of surprise